About
PhotoPharmics is a clinical-stage medical device company developing investigational photo-neuromodulation therapies to address unmet needs in Parkinson's disease by targeting retinal and circadian signaling pathways.
Explore PhotoPharmics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.